U.S. Transportation Stock News

NasdaqGS:AMGN
NasdaqGS:AMGNBiotechs

Amgen (AMGN) Could Be 45% Below Fair Value As Court Blocks Enbrel Price Cap

Amgen (AMGN) is back in focus after a federal judge blocked Colorado’s proposed 70% price cap on Enbrel, which removed an immediate regulatory threat to one of the company’s key revenue drivers. See our latest analysis for Amgen. The court decision has come on top of an already strong run in Amgen’s stock, with a 1-day share price return of 3.55% and a year to date share price return of 14.20%, while total shareholder return sits at 29.22% over one year and 87.63% over three years. This...
NasdaqGS:WSBC
NasdaqGS:WSBCBanks

WesBanco (WSBC) Leaves Russell Growth Indexes As Fair Value Views Split

WesBanco (WSBC) has been removed from several Russell growth and small cap indexes, a change that can prompt mechanical buying and selling by index tracked funds and may influence short term trading volumes. See our latest analysis for WesBanco. Despite the recent index removals, WesBanco’s share price has been firm, with a 30 day share price return of 15.27% and an 18.90% share price return year to date. Over a longer horizon, the bank’s total shareholder return of 23.01% over one year and...
NasdaqGS:VCTR
NasdaqGS:VCTRCapital Markets

3 Financial Stocks For Higher Rates In The AI Era

AI is reshaping expectations for interest rates, and that matters directly for financial sector stocks. Morgan Stanley now argues that AI driven gains could lift long term equilibrium rates, even as disinflationary effects get outweighed by stronger demand and investment. With markets paring back hopes for Federal Reserve cuts through 2026 and attention turning to upcoming FOMC meetings, investors are reassessing which large, financially strong companies might be better positioned if policy...
NYSE:FE
NYSE:FEElectric Utilities

AI Data Center Demand And Energize365 Could Be A Game Changer For FirstEnergy (FE)

FirstEnergy Corp. previously announced it would release its second-quarter 2026 results after markets closed on July 28, followed by a July 29 analyst call and webcast detailing performance and updates on its operations. At the same time, the company has highlighted rising electricity demand from AI-driven data center expansion and its Energize365 grid investment program as key forces shaping its longer-term outlook. We’ll examine how growing AI-related data center power demand, and the...
NYSE:CR
NYSE:CRMachinery

Crane (CR) Leaves Russell Defensive Indexes, Is The Premium Already Priced In?

Crane stock reaction to Russell index removal Crane (CR) came into focus after being removed from both the Russell 1000 Value-Defensive Index and the Russell 1000 Defensive Index, a change that can influence trading by index-tracking funds. See our latest analysis for Crane. The latest index changes come as Crane’s share price sits at $217.64, with a 30-day share price return of 15.24% and a 90-day share price return of 26.00%. Its 5-year total shareholder return of 273.34% reflects a strong...
NYSE:HL
NYSE:HLMetals and Mining

Hecla Mining (HL) Joined Bigger Russell Indexes, Is The Upside Already Priced In?

Hecla Mining (HL) has been reshuffled into larger benchmarks, including the Russell 1000 and Russell Midcap indices, after removals from several Russell 2000 indices. This shift is drawing fresh attention to how the stock is currently valued. See our latest analysis for Hecla Mining. Recent index moves have coincided with a sharp pickup in Hecla Mining's share price momentum, with a 1 day share price return of 4.75% and a 30 day share price return of 10.49%. This sits against a 90 day share...
NYSE:TMO
NYSE:TMOLife Sciences

How Investors May Respond To Thermo Fisher Scientific (TMO) Deepening Its Role In Late‑Stage mRNA Manufacturing

In late June and early July 2026, Arcturus Therapeutics announced a collaboration with Thermo Fisher Scientific, under which Thermo Fisher will supply integrated Phase 3 manufacturing, clinical research and potential commercial manufacturing services for ARCT-032, an investigational mRNA therapy for cystic fibrosis. This agreement aligns Thermo Fisher even more closely with cutting-edge mRNA and rare disease workflows, expanding its role as an end-to-end development and manufacturing...
NYSE:OLN
NYSE:OLNChemicals

Does Olin (OLN) Turning Hydrogen Tax Credits Into Cash Clarify Its Earnings Quality Story?

Plug Power recently sold about US$39.2 million of federal investment tax credits tied to its St. Gabriel, Louisiana hydrogen liquefaction facility, a joint venture operated with Olin and considered one of North America’s largest hydrogen liquefaction plants. This move highlights how Olin’s participation in large-scale hydrogen infrastructure can unlock value from government incentives and broaden its role in the energy transition supply chain. We’ll now examine how monetizing tax credits at...
NYSE:KEYS
NYSE:KEYSElectronic

Keysight Technologies (KEYS) Following Its GaN Design Push Is The Pullback A Buying Opportunity

Keysight Technologies (KEYS) is in focus after announcing a joint GaN MMIC design workflow with WIN Semiconductors, connecting simulation, 3D layout, and evaluation board design in one environment for high frequency applications. See our latest analysis for Keysight Technologies. Despite a sharp 1 day share price decline of 6.48% and softer 7 day and 30 day share price returns, Keysight Technologies still shows stronger momentum over longer periods. The company has a 90 day share price return...
NYSE:CL
NYSE:CLHousehold Products

How Investors Are Reacting To Colgate-Palmolive (CL) Premiumization And Omnichannel Push

In recent days, Colgate-Palmolive advanced its long-range 2030 plan, emphasizing premium product offerings, tighter digital–physical retail integration, and routine stock-based compensation grants to non-employee directors under its Deferred Compensation Plan. This renewed focus on higher-value products and omnichannel execution, backed by the company’s entrenched brands and recurring consumer demand, has sharpened investor attention on the durability of its business model. We’ll now examine...
NasdaqGM:GPCR
NasdaqGM:GPCRPharmaceuticals

Structure Therapeutics (GPCR) Is Up 7.5% After Strong Oral GLP-1 Phase 2b Data And Insider Sale - Has The Bull Case Changed?

Structure Therapeutics recently reported positive Phase 2b trial results for its oral GLP-1 obesity drug aleniglipron, published in Nature Medicine, showing durable weight loss beyond 36 weeks and improved tolerability with a lower starting dose, while its Chief Scientific Officer exercised options and sold a portion of shares under a pre-arranged Rule 10b5-1 plan. Analysts at Cantor Fitzgerald and BMO Capital responded by reiterating positive views on aleniglipron’s potential as a leading...
NasdaqGS:TSLA
NasdaqGS:TSLAAuto

How Investors May Respond To Tesla (TSLA) Record Q2 Deliveries And Margin Concerns

Tesla, Inc. reported in early July that it produced 451,758 vehicles and delivered 480,126 in the second quarter of 2026, while its energy unit deployed 13.5 GWh of storage capacity. Yet despite this record operational performance, attention quickly shifted to the quality of demand and potential margin pressure from discounts and inventory drawdowns, underscoring how sentiment now hinges more on profitability and autonomy than raw delivery growth. We’ll now examine how Tesla’s record Q2...
NYSE:FNF
NYSE:FNFInsurance

Fidelity National Financial (FNF) Earnings Miss Puts Its Undervalued Narrative To The Test

Fidelity National Financial (FNF) is back in focus after its latest quarterly update, reporting revenue of $3.23b, up 18.2% year on year but below analyst expectations, alongside a 5.1% share price decline. See our latest analysis for Fidelity National Financial. At a share price of $48.84, Fidelity National Financial has seen short term share price momentum improve, with a 7 day share price return of 4.56% and a 90 day share price return of 4.85%, even though the year to date share price...
NYSE:NFG
NYSE:NFGGas Utilities

How Investors May Respond To National Fuel Gas (NFG) Electric Fracturing Shift Using In-House Field Gas

National Fuel Gas’s Seneca Resources segment recently entered a three-year agreement with Evolution Well Services to deploy electric fracturing technology across its Appalachian operations, using produced and gathered field gas to power fracturing activity. This move highlights how pairing electric fracturing with responsibly sourced natural gas could materially change the company’s cost structure and environmental profile in its core shale business. We’ll now examine how this push into...
NasdaqGS:EXC
NasdaqGS:EXCElectric Utilities

Exelon (EXC) Faces Storm Related Strain, Is The Stock Fully Valued?

Severe storms across northern Illinois have put Exelon (EXC) in focus, as its utility subsidiary ComEd works to restore power to tens of thousands of customers facing significant outages and infrastructure strain. See our latest analysis for Exelon. Exelon’s recent operational stress test from extreme weather comes as the stock trades at US$47.88, with a 1-day share price return of 3.50% and a year to date share price return of 9.02%, while the 5 year total shareholder return of 78.34% points...
NYSE:JXN
NYSE:JXNDiversified Financial

Jackson Financial (JXN) Expands Credit Line As Fair Value Debate Stays Open

Jackson Financial (JXN) recently entered a new unsecured revolving credit facility that lifts borrowing capacity to US$1.25b and extends committed liquidity into 2031, a material move for investors watching funding flexibility and balance sheet terms. See our latest analysis for Jackson Financial. Recent share price momentum for Jackson Financial has cooled, with the share price down 3.1% over the past month and 2.8% year to date. Even so, the 1 year total shareholder return of 21.4% and the...
NasdaqGS:DKNG
NasdaqGS:DKNGHospitality

DraftKings (DKNG) Launches DKeX, Is The Stock Still A Bargain?

DraftKings launches DKeX as prediction markets milestone DraftKings (DKNG) has launched DKeX, a proprietary prediction markets exchange integrated into its unified Sports & Casino app. The move marks a new phase in its in-app prediction markets offering for investors to watch. See our latest analysis for DraftKings. DKeX arrives at a time when DraftKings’ share price has climbed 13.06% over the past 90 days but is still down 27.40% on a year to date share price return basis, with the 1 year...
NasdaqGS:CROX
NasdaqGS:CROXLuxury

Nike Stock Jump Puts Crocs And PVH In Focus For Footwear Investors

Nike’s latest quarterly update has put the spotlight back on athletic footwear and apparel stocks, with the Nike stock jump, heavy trading volume and mixed regional performance all giving fresh clues about where investor attention is heading next. For readers looking at how this news might ripple across the sector, the key question is which companies could be helped by renewed interest in running, wholesale channels and disciplined inventory, and which might feel pressure from issues like...
NasdaqCM:ASTH
NasdaqCM:ASTHHealthcare

Is Astrana Health’s (ASTH) CFO Transition Quietly Reframing Its Value-Based Care Risk Profile?

Astrana Health recently announced that Chief Accounting Officer and principal accounting officer Glenn Sobotka will retire in August 2026, with long-time internal finance leader John Vong stepping in as Senior Vice President Accounting and principal accounting officer after holding several senior roles at the company and in the healthcare sector. This orderly handover, combined with renewed investor interest in value-based care operators like Astrana Health, highlights how experienced...
NYSE:AORT
NYSE:AORTMedical Equipment

Artivion (AORT) Wins FDA Approval, Is The Stock Still 53% Undervalued?

Artivion (AORT) has drawn fresh attention after the U.S. Food and Drug Administration granted premarket approval for its AMDS Hybrid Prosthesis, expanding access to a first in class aortic arch remodeling device. See our latest analysis for Artivion. Recent price action around Artivion reflects this mix of clinical progress and index changes. The share price is $23.97 after a 19.14% 30 day share price return, set against a year to date share price decline of 46.09% and a 3 year total...
NasdaqGS:SKWD
NasdaqGS:SKWDInsurance

Is Skyward Specialty Insurance Group (SKWD) A Bargain Following Its Russell Index Reclassification?

Skyward Specialty Insurance Group (SKWD) has just been reclassified in the Russell index family, moving out of the Russell 2000 Dynamic Index and into several value oriented and defensive small cap benchmarks. See our latest analysis for Skyward Specialty Insurance Group. That reclassification comes as Skyward Specialty Insurance Group’s share price has climbed to $61.42, with a 30 day share price return of 33.64% and a 3 year total shareholder return of 145.68%, which reflects strong recent...
NYSE:TEN
NYSE:TENOil and Gas

Tsakos Energy Navigation (TEN) Adds Another LNG Carrier As Fair Value Debate Builds

Tsakos Energy Navigation (TEN) has ordered a second LNG carrier from Hyundai Heavy Industries, bringing its newbuilding program to 20 vessels and adding to secured revenue tied to long term charter commitments. See our latest analysis for Tsakos Energy Navigation. Tsakos Energy Navigation shares are trading at $37.37 after a 1-day share price return of 5.65%. This extends a strong year to date share price return of 70.72%, while the 1-year total shareholder return of 95.26% reflects sizeable...
NYSE:BBY
NYSE:BBYSpecialty Retail

Is Best Buy (BBY) Undervalued On Its Earnings Beat And Stronger Tech Demand?

Why Best Buy stock is back in the spotlight Best Buy (BBY) is drawing fresh investor attention after reporting Q1 results with year-on-year revenue growth and an earnings beat, along with management commentary pointing to stronger demand for consumer technology products. See our latest analysis for Best Buy. Best Buy’s recent earnings beat and commentary on rising tech demand have been backed up by a 21.48% 90 day share price return and a 14.20% 1 year total shareholder return, suggesting...
NYSE:SGHC
NYSE:SGHCHospitality

Is Super Group (SGHC) Cheap On Buyback Approval And Strong Earnings Expectations?

Super Group (SGHC) (NYSE:SGHC) is back in focus after shareholders approved a sizable share repurchase authorization, coinciding with earnings expectations and analyst sentiment around revenue and net income growth forecasts. See our latest analysis for Super Group (SGHC). At a share price of $14.51, Super Group (SGHC) has shown strong momentum, with a 30 day share price return of 12.13% and a 90 day share price return of 35.48%. The 3 year total shareholder return is very large, reflecting...